Valuation: Mesa Laboratories, Inc.

Market Cap 718M 640M 588M 534M 1.01B 67.4B 1.04B 7.03B 2.8B 36.02B 2.69B 2.64B 113B P/E 2027 *
60.2x
P/E 2028 * 46.1x
Enterprise Value 718M 640M 588M 534M 1.01B 67.4B 1.04B 7.03B 2.8B 36.02B 2.69B 2.64B 113B EV / Sales 2027 *
2.82x
EV / Sales 2028 * 2.65x
Free-Float
94.4%
Yield 2027 *
0.5%
Yield 2028 * 0.5%
1 day-0.34%
1 week+0.01%
Current month+0.01%
1 month+1.40%
3 months+24.52%
6 months+22.14%
Current year+62.83%
1 week 118.01
Extreme 118.01
131.86
1 month 118.01
Extreme 118.01
134.38
Current year 71.06
Extreme 71.065
144.35
1 year 69.51
Extreme 69.51
144.35
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 56 2026-04-11
Director of Finance/CFO 58 2012-10-28
Comptroller/Controller/Auditor 41 2021-12-31
Director TitleAgeSince
Chairman 73 2017-08-31
Director/Board Member 64 2024-01-04
Director/Board Member 68 2022-06-22
Date Insider Type Main position Quantity % Market Cap. Importance
9/9/26 Free

Director

2,510 0.0449%
9/9/26 Free

Director

2,423 0.0433%
9/9/26 Free

Director

1,774 0.0317%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+0.01%+68.16%+36.37% 718M
+0.53%+4.06%-12.54%+16.65% 190B
+0.97%+6.47%+11.49%+43.34% 125B
-0.04%+11.60%-8.51%+18.54% 124B
-1.65%+3.42%-38.20%+9.54% 99.31B
+3.66%+4.51%-4.14%+75.70% 63.65B
+1.59%+8.78%+21.04%-15.89% 57.71B
+4.53%+28.20%-0.25%+65.21% 53.26B
+3.53%-11.54%-8.86%+50.02% 47.03B
-0.13%+3.59%+3.73%-7.44% 36.15B
Average +1.26%+4.58%+3.19%+29.20% 80B
Weighted average by Cap. +0.98%+5.55%-6.40%+26.73%

Financials

2027 *2028 *
Net sales 254M 227M 208M 189M 359M 23.9B 368M 2.49B 994M 12.77B 955M 935M 40.19B 271M 241M 222M 202M 382M 25.44B 391M 2.65B 1.06B 13.6B 1.02B 995M 42.78B
Net income 12.7M 11.32M 10.41M 9.45M 17.93M 1.19B 18.35M 124M 49.62M 638M 47.67M 46.65M 2.01B 17.35M 15.46M 14.22M 12.91M 24.49M 1.63B 25.07M 170M 67.79M 871M 65.12M 63.72M 2.74B
Net Debt - -
Projected Income Statement - Annual - Mesa Laboratories, Inc.
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
26-11-09 US$127.82 -0.34% 118,217
26-11-06 US$128.25 +7.50% 109,672
26-11-05 US$119.30 -5.46% 107,612
26-11-04 US$126.19 +0.57% 110,563
26-11-03 US$125.48 +2.88% 91,470
Trader
-
Investor
Global
-
Quality
ESG MSCI
AA
MarketScreener Ratings - Mesa Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
127.82USD
Average target price
125.00USD
Spread / Average Target
-2.21%
  1. Stock Market
  2. Stocks
  3. MLAB Stock